Health-ISAC has partnered with Quest Diagnostics to conduct joint research into the implications of autonomous vulnerability-discovery AI technologies for the health sector. The report examines Claude Mythos, an Anthropic AI model with unprecedented offensive capabilities, including autonomous zero-day vulnerability discovery and weaponization. Outperforming previous models in both conventional and offensive security benchmarks, Mythos enables non-experts to execute complex exploits independently. For the health sector, this signals a systemic shift in risk as these autonomous tools are projected to proliferate globally by late 2026, lowering the barrier for sophisticated cyberattacks against critical infrastructure.
Key Findings
Claude Mythos Preview possesses unprecedented autonomous offensive capability, including the discovery and exploitation of zero-day vulnerabilities.
The model’s high capability creates a significant risk of misuse, similar to the abuse of tools like Cobalt Strike and Brute Ratel.
This technology is unlikely to stay in the West. Chinese firms are projected to match Mythos capabilities within 6–12 months.
Unregulated AI vulnerability discovery models, through unrestricted rollouts or open source offerings, are expected to proliferate the internet by mid-to-late 2026.
